Stem cell jab aims to save legs from amputation
NCT ID NCT05854641
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 21 times
Summary
This study tests a stem cell product called Stempeucel in 10 Malaysian adults with critical limb ischemia, a severe form of peripheral artery disease that causes pain and ulcers. The treatment is injected into the leg muscles to see if it can reduce pain, heal wounds, improve blood flow, and help patients walk farther. Participants will be followed for one year to check for side effects and benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Canselor Tunku Mukhriz
RECRUITINGKuala Lumpur, 56000, Malaysia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.